- Home
- TENB vs AAPG Comparison
TENB vs AAPG Comparison
Compare TENB & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENB
- AAPG
- Stock Information
- Founded
- TENB 2002
- AAPG 2009
- Country
- TENB United States
- AAPG China
- Employees
- TENB N/A
- AAPG N/A
- Industry
- TENB Computer Software: Prepackaged Software
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- TENB Technology
- AAPG Health Care
- Exchange
- TENB Nasdaq
- AAPG Nasdaq
- Market Cap
- TENB 3.5B
- AAPG 3.6B
- IPO Year
- TENB 2018
- AAPG 2025
- Fundamental
- Price
- TENB $27.08
- AAPG $33.87
- Analyst Decision
- TENB Buy
- AAPG Strong Buy
- Analyst Count
- TENB 17
- AAPG 3
- Target Price
- TENB $39.25
- AAPG $49.00
- AVG Volume (30 Days)
- TENB 1.2M
- AAPG 8.1K
- Earning Date
- TENB 10-29-2025
- AAPG 11-19-2025
- Dividend Yield
- TENB N/A
- AAPG N/A
- EPS Growth
- TENB N/A
- AAPG N/A
- EPS
- TENB N/A
- AAPG N/A
- Revenue
- TENB $974,603,000.00
- AAPG $54,524,554.00
- Revenue This Year
- TENB $12.22
- AAPG N/A
- Revenue Next Year
- TENB $7.62
- AAPG $368.64
- P/E Ratio
- TENB N/A
- AAPG N/A
- Revenue Growth
- TENB 11.05
- AAPG N/A
- 52 Week Low
- TENB $26.53
- AAPG $16.50
- 52 Week High
- TENB $45.45
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- TENB 33.61
- AAPG 47.99
- Support Level
- TENB $27.01
- AAPG $30.93
- Resistance Level
- TENB $28.39
- AAPG $34.31
- Average True Range (ATR)
- TENB 0.82
- AAPG 0.81
- MACD
- TENB -0.16
- AAPG 0.26
- Stochastic Oscillator
- TENB 13.22
- AAPG 85.99
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.